publication . Article . Other literature type . 1998

Clinical safety of a polyvalent F(ab′)2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon

Chippaux, Jean-Philippe; Lang, J.; Amadi Eddine, S; Fagot, P.; Rage, V.; Peyrieux, J.C.; Le Mener, V.;
  • Published: 01 Jan 1998 Journal: Transactions of the Royal Society of Tropical Medicine and Hygiene, volume 92, pages 657-662 (issn: 0035-9203, Copyright policy)
  • Publisher: Oxford University Press (OUP)
  • Country: United States
A large-scale clinical trial was conducted, according to World Health Organization Good Clinical Practice guidelines, in 7 centres in North Cameroon to determine the safety and efficacy of a polyvalent antivenom composed of purified F(ab')2. This study included 223 patients presenting clinically with an obvious snake bite, predominantly due to #Echis ocellatus$ (viper), the most abundant species in this savannah region. Clinical surveillance was maintained for 5 d in all patients and until the twenty-sixth day in 74% of cases. Two 10 mL ampoules of polyvalent F(ab')2 equine antivenom (Ipser Africa (TM)) were administered to each patient by intravenous infusion. ...
free text keywords: ESSAI CLINIQUE, TRAITEMENT MEDICAL, EFFICACITE, VENIN, SERPENT, ENVENIMATION, SEROTHERAPIE, PROTOCOLE D'UTILISATION, EFFET SECONDAIRE, Anaphylaxis, medicine.disease, medicine, Surgery, medicine.medical_specialty, Infusion Procedure, business.industry, business, Envenomation, Clinical trial, Serum sickness, Immunology, Anesthesia, Snake bites, Case fatality rate, Antivenom
Related Organizations
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue